Evidence map›Paper›PMID 42877293›Full record

ReviewJournal of Alzheimer's disease reports

Artificial intelligence algorithms for the prediction of cognitive decline and dementia: A theoretical-historical narrative review.

Rubén Sanz-Blasco, Miguel Ángel Fernández-Blázquez, Emilio Verche, José Antonio Muñiz-Casado, Marina Ávila-Villanueva, José María Ruiz-Sánchez de León

Abstract readReview
In one paragraph

Review in Journal of Alzheimer's disease reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rubén Sanz-BlascoDepartment of Experimental Psychology, Cognitive Processes and Speech Therapy, Faculty of Psychology, Complutense University of Madrid, Madrid, Spain.ORCID https://orcid.org/0000-0001-9926-1080
Miguel Ángel Fernández-BlázquezDepartment of Biological and Health Psychology, Faculty of Psychology, Autonomous University of Madrid, Madrid, Spain.ORCID https://orcid.org/0000-0002-9820-8699
Emilio VercheDepartment of Psychobiology and Methodology in Behavioral Sciences, Faculty of Psychology, Complutense University of Madrid, Madrid, Spain.ORCID https://orcid.org/0000-0002-6313-5733
José Antonio Muñiz-CasadoDepartment of Experimental Psychology, Cognitive Processes and Speech Therapy, Faculty of Psychology, Complutense University of Madrid, Madrid, Spain.ORCID https://orcid.org/0009-0002-2507-5407
Marina Ávila-VillanuevaDepartment of Social, Work and Differential Psychology, Faculty of Psychology, Complutense University of Madrid, Madrid, Spain.ORCID https://orcid.org/0000-0001-8537-2046
José María Ruiz-Sánchez de LeónDepartment of Experimental Psychology, Cognitive Processes and Speech Therapy, Faculty of Psychology, Complutense University of Madrid, Madrid, Spain.ORCID https://orcid.org/0000-0003-2834-0827

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Population aging has increased the prevalence of neurodegenerative disorders associated with dementia, with Alzheimer's disease remaining the leading cause worldwide. Early identification of individuals at risk of cognitive decline, particularly those with mild cognitive impairment, remains a major clinical and scientific challenge. In this context, artificial intelligence has emerged as a promising framework for prognostic modeling and for the identification of clinically relevant predictors of disease onset and progression. This narrative review provides a theoretical and historical synthesis of the main machine learning and deep learning approaches used to predict cognitive decline and dementia from multimodal data, including biomarkers, clinical and demographic variables, cognitive measures, and neuroimaging markers. The review examines the methodological evolution of the field, from traditional statistical approaches to ensemble methods and deep neural architectures, and discusses the growing role of multimodal and longitudinal data integration. It also highlights major unresolved issues, including limited external validation, reduced interpretability, restricted generalizability, and the gap between predictive performance and clinical implementation. Overall, artificial intelligence has substantially advanced prediction research in cognitive decline and dementia, but its routine clinical adoption will depend on more rigorous validation, improved transparency, and stronger integration between neuroscience, clinical practice, and data science.

Indexed as

Alzheimer's diseaseartificial intelligencedementiamachine learningmild cognitive impairmentprognosisrisk assessment

Identifiers

PMID42877293
PMCPMC13662331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.